News, events & scientific breakthroughs
Enzymlogic has entered into a research collaboration agreement with Esteve whereby Enzymlogic will direct its novel Binding Kinetics Platform to characterize selected compounds against mu-Opioid receptor.
Jan, 19th 2017
Binding kinetics platform participated as a finalist in the Health category of South Summit Startup Competition.
Oct, 6th 2016
Enzymlogic is attending the 8th international meeting on biotechnology that will be held in Bilbao, Spain, on September 28th to 30th, 2016.
Sept, 28-30th 2016
Enzymlogic is heading to Israel in September to represent Spain in one of the most incredible start-up economies in the world.
Aug, 29th 2016
Last week, Enzymlogic was honored with the Best Tech Startup Award, which recognizes technological companies that address important issues for society, put innovation at the heart of their business strategy and have demonstrated high-growth potential.
Jul, 6th 2016
A Binding Kinetics platform that that enables the discovery of better drugs and accelerates the drug discovery process.
March, 1st -2nd 2016
Enzymlogic is attending the seventh edition of the annual Spanish Drug Discovery Network Meeting. As in previous years, the objective of this conference is to discuss the latest achievements in Drug Discovery, Translational Research and Chemical Biology.
November, 12-13th 2015
A binding kinetics platform that guides the kinetic optimization of drug candidates and accelerates the drug discovery process.
March, 4-5th 2015
Enzymlogic provides binding kinetics expertise to a RETOS-COLABORACION project supported with €1.1 million funding from the Spanish Ministry of Economy and Competitiveness.
October, 22nd 2014
Enzymlogic has been selected by the Advisory Board of the Protein Kinases In Drug Discovery Conference to give an Oral Presentation on May 9 in Berlin, Germany.
May , 9th 2014
Enzymlogic is pleased to announce sponsorship of the upcoming Protein Kinases in Drug Discovery Conference held on May 8-9 in Berlin, Germany.
May , 8-9th 2014
Enzymlogic participates in the VII Annual Conference of the Biomedical Research Technological Platforms held in Barcelona on March 4th and 5th, 2014.
March , 4-5th 2014
Enzymlogic, the first Spanish Contract Research Organization specialized in molecular mechanism of drug action analysis, has announced today that it has received major funding from the National Innovation Company (ENISA).
Join Enzymlogic at the Spanish Drug Discovery Network Conference held this year in Valencia on October 24th to 25th, 2013.
October, 24-25th 2013
Enzymlogic took part in the summer course entitled "The Entrepreneurial Adventure" hosted by the Complutense University. The course took place at the Santander Financial City.
July, 15th 2013
Madri+d Foundation organized the XIIth Investment Forum to provide a meeting point for members of the madri+d Business Angel Network and entrepreneurs.
May, 31st 2013
The Center for Entrepreneurship at Autonomous University awarded Enzymlogic with the Scientific Park of Madrid Foundation Award for "The Best Scientific Project".
January, 17th 2013